These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8514272)

  • 1. Magnetic resonance imaging and different levels of iron overload in chronic liver disease.
    Rocchi E; Cassanelli M; Borghi A; Paolillo F; Pradelli M; Casalgrandi G; Burani A; Gallo E
    Hepatology; 1993 Jun; 17(6):997-1002. PubMed ID: 8514272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance and hepatic siderosis].
    Rocchi E
    Recenti Prog Med; 1994 Sep; 85(9):447-51. PubMed ID: 7938878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
    Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy.
    Dixon RM; Styles P; al-Refaie FN; Kemp GJ; Donohue SM; Wonke B; Hoffbrand AV; Radda GK; Rajagopalan B
    Hepatology; 1994 Apr; 19(4):904-10. PubMed ID: 8138264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance.
    Nielsen P; Günther U; Dürken M; Fischer R; Düllmann J
    J Lab Clin Med; 2000 May; 135(5):413-8. PubMed ID: 10811057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hepatic transferrin, transferrin receptor and ferritin genes in human siderosis.
    Pietrangelo A; Rocchi E; Ferrari A; Ventura E; Cairo G
    Hepatology; 1991 Dec; 14(6):1083-9. PubMed ID: 1959858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessmrent of iron overload in thalassaemic patients by magnetic resonance imaging: a pilot study.
    Kumar P; Jagannathan NR; Choudhry VP
    J Indian Med Assoc; 2007 Oct; 105(10):561-4, 591. PubMed ID: 18383951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Iron metabolism and enteral iron absorption in liver diseases].
    Rommel K; Gladtke E; Mähr G; Grimmel K; Burkhardt H
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1854-9. PubMed ID: 5704710
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation.
    Olthof AW; Sijens PE; Kreeftenberg HG; Kappert P; Irwan R; van der Jagt EJ; Oudkerk M
    Magn Reson Imaging; 2007 Feb; 25(2):228-31. PubMed ID: 17275618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of the iron and copper content of the liver for the differential diagnosis of chronic liver diseases].
    Schwabe U; Friedrich K
    Z Gastroenterol; 1990 Jul; 28(7):353-7. PubMed ID: 2238766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron and manganese homeostasis in chronic liver disease: relationship to pallidal T1-weighted magnetic resonance signal hyperintensity.
    Malecki EA; Devenyi AG; Barron TF; Mosher TJ; Eslinger P; Flaherty-Craig CV; Rossaro L
    Neurotoxicology; 1999 Aug; 20(4):647-52. PubMed ID: 10499363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of blood ferritin in the evaluation of hepatic siderosis in patients with porphyria cutanea tarda].
    Vozza A; Rossi A; Cicala G; Caso R; Esposito P
    G Ital Dermatol Venereol; 1988; 123(7-8):325-7. PubMed ID: 3224995
    [No Abstract]   [Full Text] [Related]  

  • 17. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic zinc in hemochromatosis.
    Adams PC; Bradley C; Frei JV
    Clin Invest Med; 1991 Feb; 14(1):16-20. PubMed ID: 2040101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary hepatic hemochromatosis: diagnosis and quantification with 0.5 T magnetic resonance. Value and limitations].
    Tamburrini O; Andò S; Della Sala M; Maggiolini M; Sessa M
    Radiol Med; 1993 Dec; 86(6):841-6. PubMed ID: 8296005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic-susceptibility measurement of human iron stores.
    Brittenham GM; Farrell DE; Harris JW; Feldman ES; Danish EH; Muir WA; Tripp JH; Bellon EM
    N Engl J Med; 1982 Dec; 307(27):1671-5. PubMed ID: 7144866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.